NCT02256852View on ClinicalTrials.gov

Exploratory Study of QBKPN SSI in Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Non-Small Cell Lung Cancer
Interventions
BIOLOGICAL

QBKPN SSI

QBKPN SSI is administered subcutaneously for 12 weeks

Trial Locations (1)

Unknown

BC Cancer Research Centre, Vancouver

All Listed Sponsors
lead

Qu Biologics Inc.

INDUSTRY

NCT02256852 - Exploratory Study of QBKPN SSI in Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter